nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloprost—PTGIR—endothelium—acquired immunodeficiency syndrome	0.0351	0.0606	CbGeAlD
Iloprost—PTGIR—blood plasma—acquired immunodeficiency syndrome	0.0312	0.0538	CbGeAlD
Iloprost—PLAT—retina—acquired immunodeficiency syndrome	0.0217	0.0374	CbGeAlD
Iloprost—SLCO3A1—retina—acquired immunodeficiency syndrome	0.0151	0.026	CbGeAlD
Iloprost—PTGER1—nervous system—acquired immunodeficiency syndrome	0.015	0.0259	CbGeAlD
Iloprost—PTGER1—central nervous system—acquired immunodeficiency syndrome	0.0144	0.0249	CbGeAlD
Iloprost—PLAT—spinal cord—acquired immunodeficiency syndrome	0.014	0.0241	CbGeAlD
Iloprost—PLAT—vagina—acquired immunodeficiency syndrome	0.0134	0.0232	CbGeAlD
Iloprost—SLCO2A1—skin of body—acquired immunodeficiency syndrome	0.0131	0.0226	CbGeAlD
Iloprost—PLAT—lung—acquired immunodeficiency syndrome	0.0127	0.022	CbGeAlD
Iloprost—PDE4C—nervous system—acquired immunodeficiency syndrome	0.0122	0.0211	CbGeAlD
Iloprost—PTGIR—digestive system—acquired immunodeficiency syndrome	0.012	0.0207	CbGeAlD
Iloprost—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.0118	0.0203	CbGeAlD
Iloprost—PDE4D—lung—acquired immunodeficiency syndrome	0.0116	0.0201	CbGeAlD
Iloprost—PTGIR—blood—acquired immunodeficiency syndrome	0.0114	0.0197	CbGeAlD
Iloprost—PTGIR—spinal cord—acquired immunodeficiency syndrome	0.011	0.019	CbGeAlD
Iloprost—PDE4A—lung—acquired immunodeficiency syndrome	0.0103	0.0178	CbGeAlD
Iloprost—SLCO3A1—blood—acquired immunodeficiency syndrome	0.0101	0.0174	CbGeAlD
Iloprost—PTGIR—lung—acquired immunodeficiency syndrome	0.01	0.0173	CbGeAlD
Iloprost—SLCO3A1—spinal cord—acquired immunodeficiency syndrome	0.00971	0.0168	CbGeAlD
Iloprost—PDE4C—brain—acquired immunodeficiency syndrome	0.00935	0.0161	CbGeAlD
Iloprost—SLCO3A1—vagina—acquired immunodeficiency syndrome	0.00934	0.0161	CbGeAlD
Iloprost—PTGIR—nervous system—acquired immunodeficiency syndrome	0.00927	0.016	CbGeAlD
Iloprost—SLCO2A1—vagina—acquired immunodeficiency syndrome	0.00925	0.016	CbGeAlD
Iloprost—PLAT—brain—acquired immunodeficiency syndrome	0.009	0.0155	CbGeAlD
Iloprost—PTGIR—central nervous system—acquired immunodeficiency syndrome	0.00893	0.0154	CbGeAlD
Iloprost—SLCO3A1—lung—acquired immunodeficiency syndrome	0.00884	0.0153	CbGeAlD
Iloprost—SLCO2A1—lung—acquired immunodeficiency syndrome	0.00875	0.0151	CbGeAlD
Iloprost—PLAT—lymph node—acquired immunodeficiency syndrome	0.0087	0.015	CbGeAlD
Iloprost—PDE4D—brain—acquired immunodeficiency syndrome	0.00823	0.0142	CbGeAlD
Iloprost—SLCO3A1—nervous system—acquired immunodeficiency syndrome	0.00818	0.0141	CbGeAlD
Iloprost—SLCO2A1—nervous system—acquired immunodeficiency syndrome	0.0081	0.014	CbGeAlD
Iloprost—PDE4D—lymph node—acquired immunodeficiency syndrome	0.00795	0.0137	CbGeAlD
Iloprost—SLCO3A1—central nervous system—acquired immunodeficiency syndrome	0.00788	0.0136	CbGeAlD
Iloprost—SLCO2A1—central nervous system—acquired immunodeficiency syndrome	0.0078	0.0135	CbGeAlD
Iloprost—SLCO2B1—digestive system—acquired immunodeficiency syndrome	0.0075	0.0129	CbGeAlD
Iloprost—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00744	0.0128	CbGeAlD
Iloprost—PDE4A—brain—acquired immunodeficiency syndrome	0.00728	0.0126	CbGeAlD
Iloprost—PTGIR—brain—acquired immunodeficiency syndrome	0.00709	0.0122	CbGeAlD
Iloprost—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00704	0.0122	CbGeAlD
Iloprost—PDE4B—blood—acquired immunodeficiency syndrome	0.007	0.0121	CbGeAlD
Iloprost—SLCO2B1—spinal cord—acquired immunodeficiency syndrome	0.00688	0.0119	CbGeAlD
Iloprost—PTGIR—lymph node—acquired immunodeficiency syndrome	0.00685	0.0118	CbGeAlD
Iloprost—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.00677	0.0117	CbGeAlD
Iloprost—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.00674	0.0116	CbGeAlD
Iloprost—PDE4B—vagina—acquired immunodeficiency syndrome	0.00649	0.0112	CbGeAlD
Iloprost—SLCO2B1—lung—acquired immunodeficiency syndrome	0.00626	0.0108	CbGeAlD
Iloprost—SLCO3A1—brain—acquired immunodeficiency syndrome	0.00625	0.0108	CbGeAlD
Iloprost—SLCO2A1—brain—acquired immunodeficiency syndrome	0.00619	0.0107	CbGeAlD
Iloprost—PDE4B—lung—acquired immunodeficiency syndrome	0.00614	0.0106	CbGeAlD
Iloprost—SLCO3A1—lymph node—acquired immunodeficiency syndrome	0.00604	0.0104	CbGeAlD
Iloprost—SLCO2A1—lymph node—acquired immunodeficiency syndrome	0.00599	0.0103	CbGeAlD
Iloprost—SLCO2B1—nervous system—acquired immunodeficiency syndrome	0.0058	0.01	CbGeAlD
Iloprost—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00568	0.00981	CbGeAlD
Iloprost—SLCO2B1—central nervous system—acquired immunodeficiency syndrome	0.00559	0.00964	CbGeAlD
Iloprost—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00547	0.00945	CbGeAlD
Iloprost—SLCO2B1—brain—acquired immunodeficiency syndrome	0.00443	0.00765	CbGeAlD
Iloprost—PDE4B—brain—acquired immunodeficiency syndrome	0.00434	0.0075	CbGeAlD
Iloprost—SLCO2B1—lymph node—acquired immunodeficiency syndrome	0.00428	0.0074	CbGeAlD
Iloprost—PDE4B—lymph node—acquired immunodeficiency syndrome	0.0042	0.00725	CbGeAlD
Iloprost—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00219	0.0052	CbGpPWpGaD
Iloprost—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00219	0.0052	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00216	0.00515	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.002	0.00476	CbGpPWpGaD
Iloprost—PLAT—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.002	0.00476	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00199	0.00474	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00199	0.00474	CbGpPWpGaD
Iloprost—PLAT—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.00197	0.00468	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00188	0.00446	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00188	0.00446	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00188	0.00446	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00188	0.00446	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00179	0.00427	CbGpPWpGaD
Iloprost—SLCO2A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.00174	0.00413	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00168	0.00399	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00168	0.00399	CbGpPWpGaD
Iloprost—SLCO3A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.00165	0.00392	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00161	0.00384	CbGpPWpGaD
Iloprost—PLAT—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00159	0.00378	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00158	0.00376	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00154	0.00367	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00152	0.00361	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00152	0.00361	CbGpPWpGaD
Iloprost—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0015	0.00357	CbGpPWpGaD
Iloprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0015	0.00357	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00143	0.0034	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00143	0.00339	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0014	0.00332	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0014	0.00332	CbGpPWpGaD
Iloprost—PLAT—Senescence and Autophagy in Cancer—IL6—acquired immunodeficiency syndrome	0.00138	0.00328	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00138	0.00328	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00136	0.00323	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00136	0.00323	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00134	0.00319	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00131	0.00312	CbGpPWpGaD
Iloprost—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00129	0.00305	CbGpPWpGaD
Iloprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00129	0.00305	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00128	0.00304	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.00126	0.003	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00126	0.003	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00126	0.003	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00125	0.00296	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.00122	0.00291	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00121	0.00288	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00119	0.00282	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00118	0.00281	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0011	0.00261	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00109	0.00258	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00109	0.00258	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00109	0.00258	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00109	0.00258	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000983	0.00234	CbGpPWpGaD
Iloprost—PTGER1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000979	0.00233	CbGpPWpGaD
Iloprost—PTGIR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000979	0.00233	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000978	0.00232	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000974	0.00231	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000957	0.00227	CbGpPWpGaD
Iloprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000956	0.00227	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000935	0.00222	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000935	0.00222	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000916	0.00218	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000916	0.00218	CbGpPWpGaD
Iloprost—PLAT—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000889	0.00211	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000884	0.0021	CbGpPWpGaD
Iloprost—SLCO2A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000884	0.0021	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000862	0.00205	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000862	0.00205	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000858	0.00204	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000858	0.00204	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000851	0.00202	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000848	0.00202	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000846	0.00201	CbGpPWpGaD
Iloprost—SLCO3A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000838	0.00199	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000832	0.00198	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000832	0.00198	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000824	0.00196	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000824	0.00196	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000824	0.00196	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000824	0.00196	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000823	0.00196	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000814	0.00193	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000814	0.00193	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00081	0.00193	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000807	0.00192	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000807	0.00192	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000807	0.00192	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000807	0.00192	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000807	0.00192	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000797	0.00189	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000797	0.00189	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000779	0.00185	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000779	0.00185	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000775	0.00184	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000775	0.00184	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00077	0.00183	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000759	0.0018	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000759	0.0018	CbGpPWpGaD
Iloprost—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000756	0.0018	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00075	0.00178	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000747	0.00177	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000745	0.00177	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000745	0.00177	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000736	0.00175	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000733	0.00174	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000733	0.00174	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000733	0.00174	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000733	0.00174	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000733	0.00174	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000724	0.00172	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000724	0.00172	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000717	0.0017	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000717	0.0017	CbGpPWpGaD
Iloprost—PLAT—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000712	0.00169	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000702	0.00167	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000702	0.00167	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000701	0.00167	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000697	0.00166	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000689	0.00164	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000689	0.00164	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000686	0.00163	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000678	0.00161	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000672	0.0016	CbGpPWpGaD
Iloprost—PLAT—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000667	0.00159	CbGpPWpGaD
Iloprost—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000666	0.00158	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000648	0.00154	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000638	0.00152	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000638	0.00152	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000633	0.0015	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000628	0.00149	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000624	0.00148	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000623	0.00148	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000614	0.00146	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000614	0.00146	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000608	0.00144	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000606	0.00144	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000605	0.00144	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000605	0.00144	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000597	0.00142	CbGpPWpGaD
Iloprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000589	0.0014	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000578	0.00137	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000577	0.00137	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000571	0.00136	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000571	0.00136	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00057	0.00135	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000569	0.00135	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000558	0.00133	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000558	0.00133	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000553	0.00131	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000553	0.00131	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000551	0.00131	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000549	0.00131	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000549	0.00131	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000546	0.0013	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000542	0.00129	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000534	0.00127	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000526	0.00125	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000524	0.00125	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000522	0.00124	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00052	0.00124	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000516	0.00123	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000509	0.00121	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000509	0.00121	CbGpPWpGaD
Iloprost—PTGIR—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000506	0.0012	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000503	0.0012	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000502	0.00119	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000502	0.00119	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000496	0.00118	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000491	0.00117	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000491	0.00117	CbGpPWpGaD
Iloprost—SLCO2B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000486	0.00115	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000485	0.00115	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000481	0.00114	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000479	0.00114	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000478	0.00114	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000472	0.00112	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00046	0.00109	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00046	0.00109	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000455	0.00108	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000443	0.00105	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000437	0.00104	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000435	0.00103	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000433	0.00103	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000433	0.00103	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000433	0.00103	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000433	0.00103	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000433	0.00103	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000428	0.00102	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000428	0.00102	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000428	0.00102	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000407	0.000967	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000407	0.000967	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000401	0.000952	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000392	0.000931	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000377	0.000895	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000377	0.000895	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000374	0.000888	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000368	0.000875	CbGpPWpGaD
Iloprost—PDE4C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000363	0.000862	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000337	0.0008	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000329	0.000783	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000329	0.000783	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000329	0.000783	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000325	0.000773	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000324	0.000771	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000324	0.000771	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00032	0.000762	CbGpPWpGaD
Iloprost—PTGIR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00032	0.00076	CbGpPWpGaD
Iloprost—PTGER1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00032	0.00076	CbGpPWpGaD
Iloprost—PDE4D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000316	0.00075	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00031	0.000736	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000305	0.000725	CbGpPWpGaD
Iloprost—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.0003	0.000714	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000297	0.000705	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000297	0.000705	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000293	0.000697	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00029	0.00069	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00029	0.00069	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000287	0.000681	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000287	0.000681	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000282	0.000671	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000279	0.000663	CbGpPWpGaD
Iloprost—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000278	0.000661	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000273	0.000649	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000258	0.000613	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000252	0.0006	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000226	0.000538	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000195	0.000462	CbGpPWpGaD
Iloprost—PDE4C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000194	0.00046	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000171	0.000407	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000171	0.000407	CbGpPWpGaD
Iloprost—PTGIR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000171	0.000405	CbGpPWpGaD
Iloprost—PTGER1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000171	0.000405	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000169	0.000402	CbGpPWpGaD
Iloprost—PDE4D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000168	0.0004	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000161	0.000383	CbGpPWpGaD
Iloprost—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00016	0.000381	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000149	0.000354	CbGpPWpGaD
Iloprost—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000148	0.000353	CbGpPWpGaD
Iloprost—PLAT—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000133	0.000316	CbGpPWpGaD
Iloprost—PDE4C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000114	0.000272	CbGpPWpGaD
Iloprost—PTGIR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000101	0.000239	CbGpPWpGaD
Iloprost—PTGER1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000101	0.000239	CbGpPWpGaD
Iloprost—PDE4D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.95e-05	0.000237	CbGpPWpGaD
Iloprost—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.47e-05	0.000225	CbGpPWpGaD
Iloprost—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.77e-05	0.000208	CbGpPWpGaD
